Search

Search Results
Results 16431 - 16440 of 18048 for breast cancer
  • News - 12 Feb 2024
    Heart disease is the leading cause of death among women, and women who have complications during pregnancy, such as high blood pressure or gestational diabetes, have a significantly higher risk of...
  • White Paper - 1 Feb 2024
    This article explores disease state primary cells for use in verification and validation (V&V) studies.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Nextstellis intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Varivax intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Emend IV intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Alimta (pemetrexed disodium heptahydrate) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Androfeme 1 intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Opdualag intended for persons living in Australia.
  • News - 19 Jan 2024
    The most important support person for women to succeed in their ambition to breastfeed is the new mother's partner. The partner also needs to be included through more support from healthcare...
  • Equipment - 22 Nov 2023
    This product profile describes Cadherins’ features and their role in biomedical research.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.